NPI: 1740244987 · CHESAPEAKE, VA 23320 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 24,401 | $167K |
| 2019 | 22,050 | $197K |
| 2020 | 14,493 | $235K |
| 2021 | 15,152 | $343K |
| 2022 | 13,496 | $380K |
| 2023 | 8,624 | $340K |
| 2024 | 910 | $60K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 31,243 | 1,944 | $1.61M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,226 | 1,533 | $97K |
| J1756 | Injection, iron sucrose, 1 mg | 5,971 | 1,220 | $6K |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,928 | 1,160 | $2K |
| A4657 | Syringe, with or without needle, each | 4,517 | 1,608 | $608.82 |
| G0008 | Administration of influenza virus vaccine | 70 | 54 | $269.74 |
| 90674 | 49 | 39 | $38.14 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 635 | 352 | $32.08 |
| 82728 | 798 | 574 | $19.44 | |
| 83970 | 1,017 | 682 | $13.00 | |
| 83550 | 808 | 573 | $12.46 | |
| 83540 | 808 | 574 | $9.24 | |
| 85041 | 1,369 | 945 | $5.10 | |
| 85048 | 1,317 | 919 | $4.29 | |
| 82108 | 370 | 264 | $1.63 |